文献速递血栓与止血

癌症相关静脉血栓栓塞症的治疗策略

How I treat cancer-associated venous thromboembolism.
PubMed 文献 · Blood · 2018-11-26

本文综述癌症相关静脉血栓栓塞症(VTE)的管理,讨论常见临床场景并批判性评估现有证据以指导治疗决策。癌症相关VTE是癌症常见并发症,与显著发病率和死亡率相关,多种癌症相关危险因素参与其发生。

要点

  • 癌症相关VTE包括深静脉血栓和肺栓塞,是癌症常见并发症。
  • 癌症类型与分期、化疗、手术、高龄和制动等是VTE危险因素。
  • 癌症分期与疗效评估的影像学检查增加VTE检出风险。

核心结论

  • 癌症相关VTE管理具有挑战性,近年来随机对照试验的发表有助于临床医生管理该患者群体。

研究设计与样本

  • 综述,讨论常见癌症相关VTE场景并批判性评估现有证据以指导治疗决策。

主要发现

  • 癌症相关VTE包括深静脉血栓和肺栓塞,是癌症常见并发症,与显著发病率和死亡率相关。
  • 癌症类型与分期、化疗、手术、高龄和制动等癌症相关危险因素促进VTE发生。
  • 癌症分期与疗效评估的影像学检查增加VTE检出风险。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, is a common complication of cancer and is associated with significant morbidity and mortality. Several cancer-related risk factors contribute to the development of VTE including cancer type and stage, chemotherapy, surgery, and patient-related factors such as advanced age and immobilization. Patients with cancer frequently undergo diagnostic imaging scans for cancer staging and treatment response evaluation, which is increasing the underlying risk of VTE detection. The management of cancer-associated VTE is challenging. Over the years, important advances have been made and, recently, randomized controlled trials have been published helping clinicians' management of this patient population. In this review, we will discuss common cancer-associated VTE scenarios and critically review available evidence to guide treatment decisions.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Kraaijpoel N, Carrier M. How I treat cancer-associated venous thromboembolism. Blood. 2018. PMID: 30478093. doi:10.1182/blood-2018-08-835595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。